Form 4: Palantir CTO Sankar Sells 375,000 Shares Under 10b5-1 Plan
Insider Transaction Report
Palantir Technologies CTO Shyam Sankar exercised options and sold 375,000 Class A Common Stock shares on August 20, 2025, as part of a pre-arranged trading plan.
Summary
- Palantir Technologies Inc.'s Chief Technology Officer and Executive Vice President, Shyam Sankar, executed a series of transactions on August 20, 2025.
- The transactions were conducted under a Rule 10b5-1 trading plan established on March 11, 2025.
- Sankar exercised 375,000 vested Class B Common Stock options, which had an exercise price of $11.38 per share.
- The resulting 375,000 Class B Common Stock shares were immediately converted into Class A Common Stock on a one-for-one basis.
- Subsequently, 375,000 shares of Class A Common Stock were sold in the open market.
- The sales occurred at weighted average prices ranging from $143.0363 to $156.0178 per share across multiple transactions.
- Following these transactions, Sankar directly holds 702,786 Class A Common Stock shares and indirectly holds 749,899 Class A Common Stock shares through the Sankar Irrevocable Remainder Trust, disclaiming beneficial ownership except for pecuniary interest.
- Sankar also beneficially owns 2,901,853 Class B Common Stock options after the exercise.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While an insider sale can sometimes be viewed negatively, the fact that it was executed under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling. The high sale prices relative to the option exercise price indicate a successful monetization of vested equity.
Positives
- The transactions were executed pursuant to a pre-existing Rule 10b5-1 trading plan, indicating a planned and not reactive sale.
- The exercise of options suggests the shares were in-the-money, reflecting value creation for the option holder.
- The sale prices for the Class A Common Stock were significantly higher than the option exercise price of $11.38, indicating a substantial gain for the reporting person.
Negatives
- A significant sale of 375,000 shares by a high-ranking executive could be perceived by some investors as a lack of confidence, although mitigated by the 10b5-1 plan.
Future Outlook
NA
Management Comments
- "This transaction is part of a related series of transactions undertaken on August 20, 2025 pursuant to a preexisting Rule 10b5-1 trading plan, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into on March 11, 2025."
- "The Reporting Person exercised 375,000 vested Class B Common Stock options, converted the resulting shares of Class B Common Stock to Class A Common Stock, and immediately sold the shares of Class A Common Stock in the open market."
- "The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."
- "The Reporting Person disclaims beneficial ownership of the shares held by the Remainder Trust, except to the extent of his pecuniary interest therein."
- "This Form 4 has been compiled based on applicable requirements to reflect the specific transactions described herein and is not intended to disclose or describe all shares and/or other equity securities owned or beneficially held by the Reporting Person."
Industry Context
This filing is a standard insider transaction report. It does not provide information to analyze broader industry trends or competitors. The sale of shares by a CTO could be seen in the context of executive compensation and liquidity management, common across many industries for long-tenured executives with significant equity holdings.
Related Party Transactions
- Shyam Sankar, Co-Trustee of the Sankar Irrevocable Remainder Trust u/a/d 4/20/2020, indirectly holds 749,899 Class A Common Stock shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
Stakeholder Impact
- Shareholders: The sale of a significant number of shares by a key executive, even if pre-planned, could lead to short-term negative sentiment or questions about management's long-term view, though the 10b5-1 plan mitigates this.
Next Steps
- The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate sale price upon request by the SEC, the Issuer, or a security holder.
- Investors seeking additional details regarding the Reporting Person's overall stock and equity holdings should refer to the Issuer's Proxy Statement filed on April 25, 2025.
Key Dates
| Date | Description |
|---|---|
| 2020-04-20 | Date of the Sankar Irrevocable Remainder Trust u/a/d. |
| 2025-03-11 | Date Rule 10b5-1 trading plan was entered into. |
| 2025-04-25 | Date of Issuer's Proxy Statement filing, referenced for additional stock and equity holdings details. |
| 2025-08-20 | Date of option exercise and subsequent stock sales. |
| 2025-08-20 | Date the exercised employee stock options became exercisable. |
| 2025-08-22 | Signature date of the Form 4 filing. |
| 2032-08-20 | Expiration date of the exercised employee stock options. |
Recommendation
holdThe filing details a pre-planned insider sale by a key executive, which is a routine event for long-tenured executives monetizing vested equity. While a large sale can sometimes create negative sentiment, the 10b5-1 plan indicates it is not based on new, material non-public information. The transaction itself does not provide new fundamental information about the company's operations or future prospects. Therefore, a 'hold' recommendation is appropriate, as existing investment theses should not be significantly altered by this planned transaction.
Keywords
Palantir Technologies, PLTR, Shyam Sankar, CTO, Insider Trading, Form 4, Stock Sale, Option Exercise, 10b5-1 Plan, Class A Common Stock, Class B Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.